COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN195 PARLIAMENT AND THE COUNCIL Evaluation of the implementation of the EU Drugs Strategy 2013-2020 and of the EU Action Plan on Drugs 2013-2016: a continuous need for an EU Action Plan on Drugs 2017-2020 ADD 1 ADD 1 COMMISSION STAFF WORKING DOCUMENT Evaluation of the implementation of the EU Drugs Strategy 2013-2020 and the EU Action Plan on Drugs 2013-2016 Accompanying the document above
1. The EU's Drugs Strategy 2013-2020 and its first Action Plan on Drugs 2013-2016 (which outlines actions for implementing the strategy) set the framework and priorities for the EU’s drugs policy. The Strategy provides a framework for tackling drugs inside and outside the EU, and is based on a five pillar structure: demand reduction, supply reduction, coordination, international cooperation and research.
2. This report from the Commission is a combined mid-term assessment of the EU Drugs Strategy and a final evaluation of the first Action Plan on Drugs. It finds that majority of the 54 actions in the Action Plan have been implemented: 53% of actions are completed or on track, while for 47% of actions some progress has been made but implementation is behind schedule.
3. The report recommends that a further Action Plan is now developed for the remaining span of the EU Drugs Strategy (2017-2020). Areas that the report identifies for strengthening in the new Action Plan include greater coordination with other EU policy areas, a focus on the role of the internet in drug supply and prevention, recent developments in cannabis policy, and continued action against new psychoactive substances.
|Topic||Justice & Home Affairs|